Truncated <scp>HBx</scp>‐dependent silencing of <scp>GAS2</scp> promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53‐mediated apoptosis
Ranxu Zhu(Chinese University of Hong Kong), Henry LY Chan(Chinese University of Hong Kong), Ka‐Fai To(Chinese University of Hong Kong), Yangchao Chen(Guangzhou University of Chinese Medicine), Alfred S.L. Cheng(Chinese University of Hong Kong), Myth T.S. Mok(Chinese University of Hong Kong), W.K. Yip(Chinese University of Hong Kong), Wei Kang(Chinese University of Hong Kong), Suki SK Lau(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Vincent WS Wong(Chinese University of Hong Kong), Joseph J.�Y. Sung(Nanyang Technological University)
Cited by 37
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830